The Diverse Uses of the BCG Vaccine - DR DENISE FAUSTMAN
Updated: Apr 8, 2021
Dr. Denise Faustman is a Professor at Harvard University and Director of Immunology Laboratory at Massachusetts General Hospital. She has received numerous recognition in medicine, most notably for her contribution to curing laboratory mice of Type 1 diabetes. Over the last 10 years global clinical trials in humans have started to detect beneficial human microbe effects, often at the gene level. Clinical trial data suggests the BCG microbe can serve as a platform to protect you from diverse infections, allergies, certain cancers, and human autoimmune diseases such as type 1 diabetes and multiple sclerosis. Using innovative technology and further developing BCG vaccines, Dr. Denise Faustman was able to “cure” laboratory mice of Type 1 diabetes with a forty-day course of injections with a drug called CFA, which prompts the body to produce a molecule that triggers the immune system and, in turn, tells the autoimmune cells to effectively kill themselves. During the seminar, she will focus on the mechanism behind BCGs ability to lower blood sugars in humans with long standing Type 1 diabetes at the gene level and at the protein level in the immune system, how this technology can be harnessed to cure diabetes, and its application in the development COVID-19 vaccines. There will be an open Q&A session at the end of the presentation.
🗓 Tuesday, 06th of April
⏰ 4-5:30PM GMT+1 (UK Time)